必創科技(300667.SZ):終止對創世威納的股權投資意向
格隆匯1月3日丨必創科技(300667.SZ)公佈,此前披露,公司擬通過增資、發行股份及支付現金購買資產等方式分步取得北京創世威納科技有限公司(簡稱“創世威納”或“標的公司”)控制權。截至公吿披露日,交易各方根據《意向協議》的相關約定,積極開展了各項盡職調查工作。根據初步盡職調查的結果,公司認可創世威納的技術能力和已取得的經營成果,並就本次交易的有關安排進行了溝通磋商,但交易各方就交易條件未能達成一致意見。交易各方經友好協商,一致認為本次股權投資交易條件尚未成熟,各方一致同意終止本次股權投資意向,並於2025年1月3日簽署了《股權投資意向協議之終止協議》。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.